Lv76
5000 积分 2022-01-22 加入
Development of a Risk Classifier to Predict Tumor Recurrence and Lenvatinib Benefits in Hepatocellular Carcinoma After Liver Transplantation
21天前
已完结
Postoperative circulating tumor cells predict the benefits of tyrosine kinase inhibitor for hepatocellular carcinoma after transplantation
21天前
已完结
No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant
21天前
已完结
The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study
24天前
已完结
Portal hemodynamic effects of sorafenib in patients with advanced hepatocellular carcinoma: a prospective cohort study
24天前
已完结
Portal hemodynamic effects of lenvatinib in patients with advanced hepatocellular carcinoma: A prospective cohort study
24天前
已完结
Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives
1个月前
已完结
Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review
1个月前
已完结
The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma
1个月前
已完结
TALENTOP study: a new era for conversion surgery in advanced hepatocellular carcinoma?
1个月前
已完结
皖公网安备34019202002308
